Cytokinetics, Incorporated annual revenue for fiscal 2025 was $88 million, an increase of 375.7% from $18 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $88M | $18M | $8M | $95M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $19M | $18M | $2M | $67M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More CYTK metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow
All CYTK financial statements → Interactive CYTK charts →
About TickerBase · Data methodology & sources